Location History:
- Kiyose, JP (2001)
- Nanao, JP (2002)
- Tokyo, JP (1994 - 2012)
Company Filing History:
7 out of 613 
3 out of 485 
2 out of 832,880 Years Active: 1994-2012
Title: Takafumi Kohama: Innovator in Sphingosine Kinase Research
Introduction
Takafumi Kohama is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the study of sphingosine kinases. With a total of 9 patents to his name, Kohama's work has advanced our understanding of these important enzymes.
Latest Patents
Kohama's latest patents include innovative developments in antibodies specific for mammalian sphingosine kinase type 2 isoform proteins. One notable patent describes methods of use for these antibodies, which can detect the presence of sphingosine kinase type 2 isoform. Another significant patent focuses on nucleic acids encoding mouse and human sphingosine kinase type 2 isoforms. This patent outlines methods for detecting agents or drugs that inhibit or promote sphingosine activity, as well as therapeutic agents containing peptides or antibodies to peptides encoded by such nucleic acids.
Career Highlights
Throughout his career, Takafumi Kohama has worked with esteemed organizations such as Sankyo Company, Limited and Georgetown University. His research has not only contributed to academic knowledge but has also had practical applications in the pharmaceutical industry.
Collaborations
Kohama has collaborated with notable colleagues, including Sarah Spiegel and Isao Kaneko. These partnerships have further enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Takafumi Kohama's innovative research in sphingosine kinases has led to valuable patents and collaborations that enhance our understanding of these critical proteins. His contributions continue to influence both academic research and practical applications in medicine.